🚨 Scandal Alert in Osaka! Kobayashi Pharmaceutical, a major drugmaker in Japan, is under the microscope after their popular beni-koji supplements have been linked to over 100 hospitalizations and five tragic deaths. 😱
On Saturday, officials from Japan's Ministry of Health, Labor and Welfare, alongside Osaka government departments, swooped into Kobayashi's Osaka factory. The company, caught off guard, claimed they were unaware of the investigation details. 🤔
News channels showed footage of investigators entering the facility, sparking concerns that more locations might be searched. Kobayashi Pharma, based in Osaka, couldn't be reached for comments—probably a hectic day at the office! 📞🚫
The plot thickened when Kobayashi announced on Friday that they're probing a possible connection between their products and kidney disease. As of Thursday evening, a startling 114 people had been hospitalized, and five had sadly passed away after consuming the supplements marketed to help lower cholesterol levels. 💊💔
The company has since started recalling their Beni-Koji products. For those who don't know, Beni-Koji contains Monascus purpureus—a red mold also used to color some foods. 🍣🔴
Adding to the drama, the Chinese Consumer Association has warned consumers to stop using the affected products, expressing concerns over the risks. ⚠️
Stay tuned for updates on this developing story. Let's hope for a swift resolution and safety for all consumers! 🙏
Reference(s):
cgtn.com
